Decline of Plus-Size Clothing Amid GLP-1 Influence

The availability of plus-size clothing in the United States is experiencing a significant decline, exacerbated by the rising popularity of GLP-1 medications, which are associated with weight loss. Retailers such as Target and Old Navy have reduced their plus-size offerings, prompting concerns among consumers about a resurgence of "skinny culture." Ann Lindsay, a plus-sized shopper, expressed frustration over the diminishing options, noting that her local Target in Chicago has removed plus sizes entirely.

CNN

Data from retail intelligence firm EDITED indicates that the availability of extended sizes for women's apparel on Target's website fell by 37% from March 2025 to March 2026, with a 30% decrease in the last six months alone. Similarly, Old Navy's plus-size options decreased by 12% compared to the previous year. Retail analysts suggest that the decline is part of a broader trend where retailers are hesitant to stock items that do not sell quickly, creating a cycle that further limits consumer access to plus sizes.

CNN

Many plus-size shoppers report that clothing options are often relegated to the back of stores or displayed on straight-size models, which diminishes their shopping experience. Colleen Marie, a 26-year-old from New York, criticized retailers for prioritizing potential weight loss over current consumer needs, stating, "Retailers are essentially saying that they’d rather wait for us to get smaller than serve us now."

CNN

Shannon Clemens, co-owner of The Plus Closet, a Nashville thrift store, noted that while some customers are dropping off clothes due to GLP-1 treatments, she does not anticipate a significant change in her business. This reflects a broader sentiment that weight fluctuations are a natural part of life, regardless of current trends.

CNN

Retailers have historically promoted inclusivity, with Old Navy's "size YES!" campaign in 2018 being a notable example. However, by 2022, the company reported a lack of expected demand for extended sizes, leading to cutbacks in physical stores. Mallorie Dunn, a researcher at Pratt Institute, explained that even stores that once attracted plus-sized customers have struggled to meet their needs, resulting in a self-fulfilling prophecy of reduced stock.

CNN

The influence of GLP-1 medications, such as Ozempic and Wegovy, is noted to have compounded existing issues in the plus-size clothing market. DXL, a retailer specializing in big and tall apparel, reported that up to 25% of its customers are on weight-loss drugs, which has led to a decrease in clothing purchases until consumers reach their target weights.

CNN

Critics argue that the decline in plus-size options is being used as an excuse to marginalize plus-sized individuals further. Kimmy Garris, a plus-size fashion influencer, stated, “(GLP-1s are) just an excuse for retailers to continue to push fat people out of the space.” Retail analysts, including Simeon Siegel, acknowledge that while GLP-1s are impacting retail dynamics, the underlying issue of demand for plus sizes has been a long-standing problem.

CNN

The reduction of plus-size clothing options in major retailers reflects a complex interplay of consumer demand, economic pressures, and the influence of weight-loss medications. As retailers navigate these challenges, plus-size shoppers continue to advocate for greater inclusivity and representation in the fashion industry.

CNN